SB-242235

• Description:

  A selective p38 MAPK inhibitor; inhibits IL-1 beta induction of p38 MAPK in primary human chondrocytes with IC50 of 1 uM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  353.3934

• Molecular Formula:

  C19H20FN5O

• Notes:

  Research use only, not for human use.

• Receptor:

  P38MAPK

• CAS Number:

  193746-75-7